Surmodics | SRDX - Ebit


Surmodics reported $-322K in EBIT for its fiscal quarter ending in December of 2023.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Anika Therapeutics USD -4.28M 3.58M Mar/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
J&J USD 5.11B 2.3B Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Option Care Health USD 91.5M 6.99M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -322K 2.13M Dec/2023
Trinity Biotech USD -10.02M 8.31M Dec/2024